Given the establishment of the importance of IGF1R axis in gliomagenesis and TICs maintenance, at least the ones related to OPCs, in the current study, interruption of the communication from the ligand side can be a novel strategy for IGF1R‐based anti‐glioma therapy. This evidence concerns the gene IGF1R and glioma.